Cargando…
Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
The enormous sequence diversity between human immunodeficiency virus type 1 (HIV-1) strains poses a major roadblock for generating a broadly protective vaccine. Many experimental HIV-1 vaccine efforts are therefore aimed at eliciting broadly neutralizing antibodies (bNAbs) that are capable of neutra...
Autores principales: | Brinkkemper, Mitch, Sliepen, Kwinten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789800/ https://www.ncbi.nlm.nih.gov/pubmed/31362378 http://dx.doi.org/10.3390/vaccines7030076 |
Ejemplares similares
-
Strategies for inducing effective neutralizing antibody responses against HIV-1
por: del Moral-Sánchez, Iván, et al.
Publicado: (2019) -
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023) -
Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022) -
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
por: del Moral-Sánchez, Iván, et al.
Publicado: (2022) -
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)